CLINDAMYCIN PHOSPHATE | A064050 | PADAGIS US LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Macleods Pharmaceuticals Limited FDA-2019-P-4481 · 8 docket documents Macleods Pharmaceuticals Limited submitted this citizen petition under Section 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA designate the approved generic product ANDA #064050, Clindamycin phosphate topical solution 1% manufactured by Perrigo New York Inc., as a referen | Other | 2019-09-26 | Withdrawn | Macleods Pharmaceuticals Limited |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1985
per ml
Lowest NADAC/Unit
$0.1539
per ml
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 45802056201CLINDAMYCIN PH 1% SOLUTION | $0.1985 | ML | Generic | — | 2026-06-17 |
| 45802056202CLINDAMYCIN PH 1% SOLUTION | $0.1539 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.